Autism Spectrum Disorders (ASDs) are a heterogeneous collection of neurodevelopmental disorders with a strong genetic basis. Recent studies identified that a single hit of either a de novo or transmitted gene-disrupting, or likely gene-disrupting, mutation in a subset of 65 strongly associated genes can be sufficient to generate an ASD phenotype. We took advantage of consanguineous families with an ASD proband to evaluate this model. By a genome-wide homozygosity mapping of ten families with eleven children displaying ASD, we identified a linkage region of 133 kb in five families at the 3p14.2 locus that includes FEZF2 with a LOD score of 5.8 suggesting a founder effect. Sequencing FEZF2 revealed a common deletion of four codons. However, the damaging FEZF2 mutation did not appear to be sufficient to induce the disease as non-affected parents also carry the mutation and, similarly, Fezf2 knockout mouse embryos electroporated with the mutant human FEZF2 construct did not display any obvious defects in the corticospinal tract, a pathway whose development depends on FEZF2. We extended the genetic analysis of these five FEZF2-linked families versus five FEZF2 non-linked families by studying de novo and transmitted copy number variation (CNV) and performing Whole Exome Sequencing (WES). We identified damaging mutations in the subset of 65 genes strongly associated with ASD whose co-expression analysis suggests an impact on the prefrontal cortex during the mid-fetal periods. From these results, we propose that both FEZF2 deletion and multiple hits in the repertoire of these 65 genes are necessary to generate an ASD phenotype.
Introduction
The genetics and genomics of neuropsychiatric disorders (NPDs) have made unprecedented progress recently, in particular for unravelling the genetic architecture of Autism Spectrum Disorders (ASDs) (1, 2) . ASD is a phenotypically and genetically heterogeneous neurodevelopmental condition that is characterized by deficits in reciprocal social interaction, repetitive behavior patterns, and restricted interests (3) , with a prevalence as high as 1 in 68 children (4) . Both de novo and transmitted multiple definitive risk-carrying copy number variations (CNVs), protein-altering mutations, and/or non-coding alleles have been identified in ASD (5, 6) . Recent studies leveraged the statistical power afforded by rare de novo putatively damaging variants and have identified more than 65 strongly associated or highconfidence genes (5) . The most deleterious variants that are likely gene-disrupting in the highest confidence subset (False Discovery Rate, FDR ≤ 0.01) of these genes (n = 30) as a group confer ∼20-fold increase in risk (5) . To date, there is very little evidence for a multi-hit hypothesis vis-á-vis these highly damaging de novo coding mutations (6) . Willsey et al. proposed a model with a single highly protein-disrupting mutation causing functional haploinsufficiency and thus sufficient to confer these very large risks (6) .
Our aim was to study consanguineous families with autism probands in order to test whether the single hit model applies to these families with a possible founder effect, and whether single hit high-risk genes are part of these 65 strongly associated genes.
Homozygosity mapping in pedigrees with shared ancestry has been a powerful methodology to identify autosomal recessive disease genes in ASDs and to advance our understanding of the genetic architecture of these complex diseases (7, 8, 9) . Here, we identified ten simplex, consanguineous families from Morocco and performed whole-genome linkage studies and whole-exome sequencing (WES) in order to validate a genetic architecture based either on a single hit model or on multiple hits. Supplementary Table S1 Supplementary Table S2 Supplementary Table S3 We used homozygosity mapping, CNV analysis followed by WES, and Sanger sequencing strategies to identify disease-related mutations in ten trios (parents and affected child) from consanguineous ASD families.
Results

Homozygosity mapping implicates FEZF2-linked locus in ASD etiology
We first performed a genome-wide homozygosity mapping linkage analysis in ten trios in which the parents are either first or second cousins. All patients were examined and diagnosed using ADI-R ( Supplementary Table S1 ). The M/F ratio of affected children in these consanguineous families was 2.6:1 (8 males, 3 females), and this ratio is comparable to the ratio found in consanguineous multiplex pedigrees from a previous study (8) . The linkage analysis revealed several genetic loci overlapping between pedigrees with strong support for linkage with logarithm of odds (LOD) scores ranging from 3.6 to 5.8 ( Supplementary Table S2 ). One region of 133 kb that includes the FEZF2 gene at 3p14.2 was identified in five families (2, 5, 6, 18, 23) and had a higher LOD score of 5.8 (Figure 1A-B) . The FEZF2 gene encodes the transcription factor required for the specification of corticospinal motor neurons (10, 11, 12) .
Altogether, these results suggest that a founder locus that includes FEZF2 is associated with ASD in five families.
FEZF2 sequencing revealed heterozygous deletions of 12bp in exon 2 (Figure 2A) . These mutations, either transmitted by one parent (father) for patients 32, 318 and 418 or arising de novo for patients 36 and 323, lead to an in-frame deletion of 4 amino acids (RLPA) (Arg237_Ala240del) in the FEZF2 protein ( Figure 2B ). This core region showed mammalian conservation ( Figure 2B) . Interestingly, haplotype analysis indicated that this FEZF2 deletion was found in different haplotypes (Figure 2C) . In our study, both transmitted and de novo FEZF2 mutations (n=4) were found in haplotype SQ4 that is linked to ASD in this group of families. In haplotype SQ1, which is the most frequent, we identified one individual from Colombia with the same RPLA mutation out of 2,535 individuals from the 1,000 genome database (http://www.internationalgenome.org/). A similar mutation was found in three patients with intellectual disability out of 2,379 screened Saudis and was also found as homozygous in one autistic behavior patient (13) . Their haplotype is either haplotype SQ4, SQ18 or SQ20
( Supplementary Table S3 ). The SQ1 (68.7%), SQ2 (8.4%) and SQ4 (5.8%) haplotypes differ by one, two and three mutational events, respectively. Multidimensional scaling (MDS) analysis of these FEZF2 locus haplotypes from the 1,000 genomes data indicated that the FEZF2 alleles from Moroccan families are related to the African FEZF2 allele ( Figure 2D) . As for other mutations found in brain diseases (14) , one can propose that the mutation arose independently in each case.
Brain MRI with and without contrast injection was performed for the autistic twins, 318 and 418 of Family 18, and for patient 32 of Family 2 (see Supplementary Table S1 ). The MRI results did not show any significant abnormalities, and no cerebral atrophy or significant cortical dysplasia were detected. Interestingly, the corpus callosum did not display any significant abnormalities.
Functional analysis of the mutant FEZF2 protein in vivo in the context of neocortical neuronal projection during embryogenesis
Supplementary Table S4
Figure 3
The FEZF2 gene (also known as FEZL, ZF312 or ZNF312) regulates the molecular identity, dendritic development and axon targeting of layer 5 corticospinal neurons in the cerebral cortex (10, 11, 12) . TBR1 directly binds to FEZF2 regulatory regions and represses its activity in Layer 6 cortico-thalamic projection neurons to restrict the origin of the corticospinal tract to layer 5 (15, 16, 17, 18) . TBR1 is one of the 20 ASD high risk candidates that confer ∼20-fold increase in risk (5) . Furthermore, cis-regulatory regions controlling the expression of FEZF2 and its targets, such as PLEX1, display evolutionarily conserved roles in the formation of direct corticospinal connections in primates (19, 20) .
Since the FEZF2 protein is conserved from mouse to human (Percent identity: 95.22% and Percent similarity: 95.43%) and the FEZF2 mutation involved conserved amino acids (RLPA amino acids), we tested the function of the mutated protein in a mouse conditional Fezf2 knockout background ( Supplementary Table S4 ).. Electroporation of either the wild-type or mutant human FEZF2 expression constructs resulted in normal corticospinal tract projections emanating from layer 5 ( Figure 3A) indicating that expression of the FEZF2 protein with the RPLA deletion is not sufficient to impact the long-distance axonal projection that characterizes FEZF2-expressing cortical neurons from Layers 5 (Figure 3B) . Given that FEZF2 regulates the fate choice of subcortical projection neurons in the developing cerebral cortex (15) , we next assessed the function of the mutant FEZF2 protein in corticospinal tract development. Using the same model as outlined above, we evidenced GFP expression in pons of electroporated embryos that expressed the mutant FEZF2 protein similar to that previously reported in control animals (10) . These results suggest that the mutant FEZF2 protein retains its normal function, at least in the context of corticospinal tract development and dendrite maturation, which is consistent with the observation that the RPLA FEZF2 mutation can be found in unaffected parents (family 2 and family 18) and is therefore not sufficient to induce an ASD phenotype ( Figure 3C ).
Identification of de novo Copy Number Variants (CNVs) and Single Nucleotide Variants (SNVs)
Figure 4
Supplementary Table S5 Supplementary Table S6 We first analyzed de novo CNVs in siblings from both FEZF2-allele linked and unlinked families ( Supplementary Table S5 ). We found 56 and 21 de novo CNVs in FEZF2-allele unlinked and linked families, respectively. This number of de novo CNVs in our cohort (found for 11 of 11 patients) is considerably higher than the previously reported number for non-consanguineous families (21) . We analyzed these de novo CNVs using Disease Association Protein-Protein Link Evaluator (DAPPLE) to study the gene networks involved. DAPPLE looks for significant physical connectivity among proteins encoded by genes in loci associated with disease according to protein-protein interactions reported in the literature (22, 23) . For de novo CNVs from FEZF2-unlinked families (N= 56), the DAPPLE network is statistically significant for indirect connections (Seed Indirect Degrees Mean, P = 7.99 x 10 -3 and Common Interactors Degrees Mean P = 3.99 x 10 -2 ) ( Figure 4A) . In contrast, for de novo CNVs from FEZF2-linked families (N=21), no significant network was found using DAPPLE. Interestingly, for the DAPPLE network of FEZF2 allele-unlinked families, nodes of the gene network involve genes encoding presynaptic proteins, synaptic receptor subunits, and adhesion molecules: PTPRD, NSF (24, 25) , GRM7, GRIK2 (26), GABRG1 (27) , ROBO2 (28), EPHA7, and ALCAM (29) .
DUSP22, a gene that encodes a protein activating the Jnk signaling pathway, was already found to be mutated in another ASD study (30) . To complement the DAPPLE analysis, we used Over-Representation Analysis (ORA) from WebGestalt suite (31) . ORA identified a network that includes GRM7 and GRIK2, genes that encode synaptic proteins, thus implicating the involvement of a GO:0007215 glutamate receptor signaling pathway (Ontology: We next performed whole exome sequencing (WES) in ten trios and confirmed by Sanger sequencing eleven de novo mutations ( Supplementary Table S6 ). We found de novo single nucleotide variants (SNVs) in ERN1, HADHB, DMKN, and STRIP2 in three FEZF2-allele linked patients and variants in SH3TC2, CDCA4, APOA, PHCTR3, Elf4G1, GRK4, and TMEM11 were found in five patients from FEZF2 allele-unlinked families. All variants were novel and not observed in the exome variant server (EVS, http://evs.gs.washington.edu/EVS/). These variants impact amino acids conserved in mammals. This ratio of 11 protein-coding de novo variants in our study is rather similar to that described for intellectual disability cases with de novo variants resulting in a total of 84 de novo mutations in the protein-coding regions for 50 patients (32 ) .
Analysis of de novo and transmitted CNVs and SNVs in FEZF2 allele-linked and unlinked families
Supplementary Figure 1
Supplementary Table S7 Supplementary Table S8 Each person inherits mutations from their parents (transmitted mutations), some of which may predispose the person to certain diseases. Meanwhile, new mutations may occur spontaneously during the reproductive process (de novo mutations) and, if disrupting key genes, may similarly increase the risks of disease. It is therefore important to study the combination of de novo and transmitted mutations.
We first performed this analysis for de novo and transmitted CNVs in these 10 consanguineous families and we found 337 and 314 genes for CNVs of FEZF2 allele-unlinked and linked families, respectively ( Supplementary Table S5 ). We used GO to analyze the gene networks involved. In FEZF2 allele-linked families, we identified enrichment in GO: 0007156 biological process: homophilic cell adhesion via plasma membrane adhesion molecules and GO: 0050911: detection of chemical stimulus involved in sensory perception of smell classes with P=2.54 E -06 and P=1.04 E -06 , respectively. In FEZF2 allele-unlinked families, we similarly found the involvement of GO biological process GO:0007156: homophilic cell adhesion via plasma membrane adhesion molecules with P=9.25E -08 . Furthermore, DAPPLE analysis identified statistically significant networks in FEZF2 allele-linked families (Supplementary Figure 1A) and FEZF2 allele-unlinked families (Supplementary Figure 1B) . For the FEZF2 allele-linked families, the DAPPLE network is significant for both direct and indirect nodes (Direct Edges Count P = 1.99 x 10 -2 ; Seed Direct Degrees Mean P = 3.99 x 10 -3 ; CI Degrees Mean P = 5.99
x 10 -3 ). For the FEZF2 allele-unlinked families, the DAPPLE network is also significant for both direct and indirect nodes (Direct Edges Count P = 3.49 x 10 -2 ; Seed Indirect Degrees Mean P = 1.99 x 10 -2 ; CI Degrees Mean P=1.99 x 10 -3 ). Interestingly, mutations found in de novo CNVs of FEZF2 allele-unlinked families underline the importance of synaptic networks as already reported (5, 6, (33) (34) (35) . In contrast, results from transmitted and de novo CNVs of FEZF2 allelelinked and unlinked families point to distinct gene classes with adhesion proteins involved in hemophilic interactions, such as clustered protocadherins (36, 37) , that are known to be involved in the establishment of the diversity of neural circuit assemblies and olfaction pathways. Links between olfaction and autism were recently found in ASD patients (38, 39) .
From these CNV data ( Supplementary Table S5 ), we also analyzed genes repeatedly found mutated in different families. We identified 207 genes mutated in more than one family (from 2 to 10 families) ( Supplementary Table S7 ). Interestingly, their analysis by Gene Ontology found enrichment in genes of GO: 0007156~homophilic cell adhesion via plasma membrane adhesion molecules (P=1.19E -7 ), GO: 0098742~cell-cell adhesion via plasma-membrane adhesion molecules (P=2.52E -7 ) and GO: 0050911~ detection of chemical stimulus involved in sensory perception of smell (P=1.53E -9 ).
We also investigated transmitted SNVs mutations and identified 974 and 931 mutated genes in FEZF2 allele-linked and unlinked families, respectively, with the intersection of the two groups containing 211 genes ( Supplementary Table S8 ). Transmitted SNVs for FEZF2 allelelinked families (N=974) display enrichment in genes of GO biological process GO:0021795 cerebral cortex cell migration (P=2.04E -05 ) and GO:0021885 forebrain cell migration (P=1.54E -
05
). In contrast, transmitted SNVs for FEZF2 allele-unlinked families (N=931) display enrichment in genes of GO biological process GO:0007155 cell adhesion (P=1.52E -06 ). Studies leveraging the statistical power afforded by rare de novo putatively damaging variants have identified more than 65 genes strongly associated with ASD (5, 35) . The most deleterious variants in the highest confidence subset of these genes (n = 30) as a group confer ~20-fold increase in risk (5) . In four FEZF2 allele-linked families, we identified transmitted SNV mutations in eight genes strongly associated with ASD: KAT2B , DIP2A, NINL, MFRP, AKAP9, ASH1L, SCN2A, and ZNF559 (Figure 5) . In two FEZF2 allele-linked families (Family 6 and 23), the FEZF2 mutation is a de novo mutation. In five FEZF2 allele-unlinked families, we identified transmitted SNVs and CNV in six genes strongly associated with ASD: APH1A, PTK7, CTTNBP2, CHD8, SETD5, and KATNAL2 (Figure 6) . For both FEZF2 allele-linked and -unlinked families, we identified an enrichment of mutations in genes strongly associated with ASD (2.16 fold compared to expectations with a hypergeometric P value = 4.22 x 10 -3 ).
High-risk ASD genes involvement for de novo and transmitted CNVs and SNVs in both
Interestingly, from the 14 mutations identified in high-risk ASD genes, thirteen are found in transmitted SNVs and only one in a transmitted CNV (CHD8).
As mutations in ASD strongly associated genes are present in one of the unaffected parents, one can suggest that these mutations are not sufficient to generate an ASD phenotype.
Interestingly, for FEZF2 allele-linked mutations, 1 to 3 transmitted mutations in genes strongly associated with ASD are seen to coincide with the FEZF2 mutation ( Figure 5 ), indicating that a multiple hit hypothesis can be favored over the hypothesis of a single hit in a gene strongly associated with ASD and sufficient to cause disease. Characterization of the spatio-temporal pattern of expression of genes found mutated in our study can give important insights into disease mechanisms. Multiple studies demonstrated convergence of the highest-confidence non-syndromic ASD risk genes in the frontal lobe (i.e., prefrontal and primary motor cortex) in deep-layer projection neurons from 10 to 24 postconception weeks (PCW), or approximately spanning the end of the early fetal period and the entire mid-fetal period (40) (41) (42) .
Spatiotemporal co-expression of mutated high-risk genes in
We took advantage of t-distributed stochastic neighbor embedding methods by applying BrainScope (43) to explore high-dimensional data (dual t-SNE) across multiple brain regions and developmental periods from the BrainSpan consortium (44) . With this approach, we were able to distinguish different clusters for the 65 ASD risk genes defined by Sanders et al 2015 suggesting that they display distinct spatiotemporal trajectories (Figure 7A-B) . We identified a first group of genes (red) that clusters around FEZF2 and a second group (black) that clusters around KATNAL2. De novo SNVs found either in FEZF2 allele-linked and unlinked families segregated in these two different clusters.
We focused our analysis on transmitted high-risk genes and de novo SNVs identified in FEZF2 allele linked-families. In the red cluster, we identified DIP2A (Family 2), NINL (Family 6), AKAP9 (Family 18), and ZNF559 (Family 23).In the black cluster, we identified KAT2B (Family In contrast, the heatmap of the black ensemble is similar to that of KATNAL2 with high levels of postnatal expression particularly in the striatum (Supplementary Figure 2 B and D) .
Multiple sequence alignment for different proteins from phylogenetically distinct species indicated that the amino acid affected by the single nucleotide mutation was conserved through evolution, suggesting an important function for such amino acids (Supplementary Figures 3-12 ). Interestingly, ZNF559 (Red ensemble, Family 23) is a primate-specific gene belonging to a cluster of KRAB zinc finger protein (KZFP) genes, involved in gene regulation and is not older than 100 million years (45) (Supplementary Figure 13) . Regarding SCN2A (black ensemble, Family 23), mice with haploinsufficiency for the gene Scn2a displayed impaired spatial memory (46) . A missense mutation, D12N, in SNC2A in the same domain as our A34T mutation (N terminal intra-cytoplasmic domain) appears to be able to generate an ASD phenotype in humans with functional defects of sodium channels (47) . Furthermore, the product of Scn2a, NaV1.2 is critical for dendritic excitability and synaptic function in mature pyramidal neurons in addition to regulating early developmental axonal excitability (48) . From transmitted CNVs, we identified a mutated CHD8 gene in FEZF2 allele-unlinked family 20. This mutation involves the full deletion of a CHD8 exon that follows the helicase domain (Supplementary Figure 14) . To further test the multiple-hit hypothesis in FEZF2 allele-linked families 2, 6, 18 and 23, we investigated whether in all FEZF2 allele-linked families at least one of those second hits was also expressed in FEZF2-expressing cells. For this analysis, we took advantage of single-cell and single-nuclei data from fetal and adult human frontal cortex (49, 50) . In these datasets, FEZF2 is expressed in neural progenitor cells (NPC) and excitatory neurons (L5 in adult). All families carried mutations in at least one gene that is expressed in the same developmental window as FEZF2 and are also co-expressed with FEZF2 in the same cell-type (Figure 8) .
The layer distribution of these genes was further assessed using the 17 human cortex sections microarrays from (51) (Figure 9) . The analysis of the relative expression of FEZF2 across cortical sections confirmed its enrichment in layer 5. AKAP9, ASH1L and SCN2A were relatively more expressed in deeper sections of layer 5 but, contrary to FEZF2, none of them can be considered as significant layer specific markers in humans (51) . KAT2B and DIP2A
were enriched in L6 and described as L6 markers (51) despite differences in global RPKM (Reads Per Kilobase Million) expression levels (Supplementary Figure 15) . DIP2A displays a higher number of reads in deep layer compared to upper layer cells in the adult frontal cortex (Figure 8) . The layer differences observed in KAT2B might be contributed by glial cells (Figure   8 ). Independently of the degree of single-cell level expression overlap between FEZF2 and putative second hits, none of the genes displayed the exact same cortical layer distribution of FEZF2.
Discussion
The genetic architecture of ASDs remains to be fully understood in spite of the identification of contributing rare and common variants (1, 2, 5) . Our approach is based on the analysis of consanguineous families from Morocco whereas most other studies involve European and/or North American populations. The 1000 genomes project does not involve genomic data from Northern African countries. It is important to note the high level of CNVs in the Moroccan families analyzed in this study as compared to non-consangineous populations (21) . Similar high level of CNVs have been reported in studies involving consanguineous families, such as in Lebanon (52) .
Our aim was to test the hypothesis that a single damaging mutation in a limited set of high-risk genes, asproposed in previous studies (5, 6, 35) , can be sufficient to cause ASD. Our data reveal a clear multi-hit organisation involving a homozygous FEZF2 allele, a damaging FEFZ2 mutation, mutations in ASD high-risk genes, and other gene variants. Each of these variants can contribute to the genesis of an ASD phenotype. The homozygous FEZF2 allele may possibly impact on cis elements involving deregulation of the FEZF2 gene. Such cis-regulatory structural variants associated with autism have been recently described (53) . FEZF2 is also part of a developing human brain gene co-expression network enriched for neurodevelopmental disorder risk genes that includes ASD high-risk genes such as TBR1, CTTNBP2, and DSCAM (44) . Previously, genetic association has been found between FEZF2 and ASD (54) and rare mutations in the FEZF2 gene were identified in distinct ASD cohorts (55, 56) . The identification of a FEFZ2 mutation reported here underscores the importance of FEZF2 in ASD genetic architecture.
Considering our multi-hit model, further work will be needed to define the relative contribution for each mutation: the FEZF2 mutation, one to three mutations in ASD high-risk genes, and one (or no) de novo SNVs identified in FEZF2 allele-linked families (Figure 7C) . For some ASD high-risk genes, such as CDH8, SCN2A and SERD2, their haploinsufficiency in mice is sufficient to induce autistic-like phenotypes as demonstrated for CHD8 (57, 58) , SCN2A (46), and SETD5 (59) . In our case, novel mouse models that can integrate the mutations reported here can be instrumental to dissect the contribution of each mutation to phenotypes relevant of ASD. Interestingly, in each FEZF2 allele-linked family we identified a mutation in a gene that is part of the FEZF2 'red ensemble' and a mutation in a gene that is part of the KATNAL2 'black ensemble' (Figure 5 and Supplementary Figure 2) . Genes of the FEZF2 'red ensemble' that are expressed at midgestation in deep layers of the cortex may be involved in social interaction impairment as demonstrated for CDH8 (44) . In contrast, genes of the KATNAL2 'black ensemble' that are highly expressed at postnatal stages in the striatum may be responsible for stereotypies (60, 61) . How the mutations identified in FEZF2 allele-linked families contribute to layer organisation of the human cortex can be studied using induced Pluripotent Stem Cells (iPSCs). These pluripotent stem cells show a remarkable ability to self-organize and differentiate in vitro in three-dimensional aggregates, known as organoids or organ spheroids, and to recapitulate aspects of human brain development and function (62, 63) . Analysis of deep layer organization enables one to define the involvement of mutated genes discovered in patients of FEZF2 allele-linked families.
Altogether, our results highlight the genetic architecture of ASD involving a founder mutation that can be combined with other variants to increase the risk of ASD. We propose FEZF2 as a novel candidate to be sequenced in ASD, particularly in at-risk consanguineous families.
Materials and Methods
Patients and Assessments
Our data set consisted of 31 individuals from 10 consanguineous Moroccan ASD families recruited from the Child Psychiatry Center at the Arrazi Hospital (Salé -Morocco). Core inclusion criteria for ASD individuals were as follows: (1) 
Microarrays and copy number analysis
Genomic DNA was extracted from peripheral blood using a standard organic Phenol/Chloroform extraction. Genotyping with Affymetrix Genome Wide Human SNP Array 6.0 was performed using the protocol recommended by the manufacturer. In brief, a total of 2 x 250 ng of genomic DNA was used as starting material for each enzymatic digestion (Nsp and Sty) followed by linker-ligation of a common adaptor sequence. Standard PCR amplifies a predictable range of fragment sizes. The target was fragmented, hybridized to microarray, stained, and scanned. Quality controls were carried out. Affymetrix software "Genotyping Console version 4.1" was used for genotype calling, quality control, and CNV identification. 
Selecting SNVs from Polyphen2 analysis
We used PolyPhen-2 that is a new development of the PolyPhen tool for annotating coding Our criteria were (i) to have a possibly damaging in at least one of DIV and VAR parameters (pval <01) and (ii) to be a rare variant (frequency <0.01 in dbsnp38).
PCR amplification and sequencing
PCR amplifications were performed with 50ng of genomic DNA using Platinum Taq DNA Polymerase (Invitrogen) and 10µM of each human FEZF2 primer. PCR products were purified and sequenced by GATC Biotech company.
Assaying the function of the mutant 12bp deletion (d12bp) FEZF2 protein in a mouse model of corticospinal tract development
We made a construct with the 12bp deletion of FEZF2 able to generate a FEFZF2 protein with the RLPA deletion (see Supplementary Table S4 ). Both the wildtype and mutated human FEZF2 sequences were cloned into a mammalian expression vector, pCAGEN. Generation of Fezf2 Conditional Knockout Mice Fezf2 fl/fl has been described earlier (10) . Briefly, E13.5
Fezf2 fl/fl mouse embryos were electroporated in utero with a combination of three expression constructs; pCAG-Cre to excise the endogenous mouse Fezf2 gene, pCALNL-GFP to visualize transfected cells, and either pCAG-FEZF2 to express the wildtype human FEZF2 protein or pCAG-d12bp-FEZF2 to express the mutant FEZF2 protein carrying the 12bp deletion.
Electroporations were targeted to layer 5 of the cortex. The effect on corticospinal tract development was assessed at P0 by analysis of GFP-labelled projections in coronal brain sections (cortex and pons, respectively).
Whole exome sequencing
We performed exome-sequencing with Illumina HISEQ using the manufacturer's protocol.
Quality control, alignment and calling were made with GATK suite. We used a Bayesian approach for filtering out false-positive calls. We used microarray data and exome-sequencing calls in order to establish two classes of calls: true positive (TP) and false-positive (FP). If the call in the microarray is equal to the call in the exome-sequencing we class it TP, otherwise we class it FP. We classed calls by the average coverage by site, i.e. we divide by 31 (the number of individuals) the total number of reads for a site, we separate heterozygous calls from homozygous calls. According to DP mean and states (heterozygous or homozygous), we constructed empirical distributions for GATK parameters and for TP and FP. We estimated a Bayes Factor (BF) for the call and we filtered out all calls with a log(BF)<3 and read depth<20.
We used Sanger sequencing to perform validation of variants.
Networks bioinformatics analyses
We used DAPPLE and WebGestalt suites. Disease Association Protein-Protein Link Evaluator (DAPPLE) looks for significant physical connectivity among proteins encoded for by genes in loci associated to disease according to protein-protein interactions reported in the literature (22) . Interactions are extracted from the database "InWeb" that combines data from a variety of public PPI sources including MINT, BIND, IntAct and KEGG and defines high confidence interactions as those seen in multiple independent experiments. Connections can be direct (two proteins are physically linked to each other) and indirect (interaction is mediated by a common interactor). The non-randomness of the network and the significance of the interaction parameters are tested using a permutation method that compares the original network with thousands of networks created by randomly re-assigning the protein names while keeping the overall structure (size and number of interactions) of the original network. To complement the DAPPLE analysis, we used Over-Representation Analysis (ORA) from WebGestalt suite (31) .
t-distributed stochastic neighbor embedding methods
We took advantage of t-distributed stochastic neighbor embedding methods by applying BrainScope (43) to explore high-dimensional data (dual t-SNE) across multiple brain regions and developmental periods from the BrainSpan consortium (44) .
Gene co-expression analysis
Cell gene counts from fetal and adult human frontal cortex were obtained from Zhong et al.
2018 and Lake et al. 2017, respectively (49, 50) . Counts were log-normalized using Seurat V3 (Stuart et al. 2019 ) and a scale factor of 10,000. In order to calculate the proportion of cells expressing or not expressing a given gene, a gene was considered expressed in one cell if its normalized value was greater than or equal to 1.
Cortical layer expression
RPKM from the 17 cortical sections were obtained from He et al. 2017 (51) . To represent relative expression across sections for each gene, we scaled RPKM values to be between 0 and 1 by subtracting the minimum and dividing by the maximum minus the minimum.
Haplotype Network reconstruction
Network reconstruction of all carrier and non-carrier haplotypes was obtained using the median-joining algorithm implemented in NETWORK v.4.5.1 (Bandelt et al., 1999) .
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Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Consanguineous pedigrees with ASD in four FEZF2 allele-linked families: Family 2 whose autistic child displayed the transmitted mutations in the FEZF2, DIP2A, and KAT2B genes as well as the de novo SNV in the ERN1 gene. Family 6 whose autistic child displayed de novo mutations in the FEZF2 and STRIP2 genes as well as a transmitted mutation in NINL gene. Family 18 whose twin autistic children displayed transmitted mutations in the FEZF2, AKAP9 and MFRP genes. Family 23 whose autistic child displayed the de novo mutation in FEZF2 and transmitted mutations in the ASH1L, SCN2A and ZNF559 genes. Squares indicate males and circles indicate females. Individuals affected with ASD are presented as black symbols, white symbols are unaffected. †de NOVO SNV, § transmitted SNV
Figure 6. Multiple damaging mutations in the high-risk genes in FEZF2 allele-unlinked families
Family 3 whose autistic child displayed the transmitted SNV in the APH1A gene. Family 4 whose autistic child displayed the de novo SNVs in the APOA1 and PHACTR3 genes. Family 15 whose autistic child displayed transmitted SNVs in the PTK7, P2RX1 and CTTNBP2 genes. Family 20 whose autistic child displayed the transmitted CNV within the CHD8 gene, the transmitted SNV in the SETD5 gene and de novo SNV in the TMEM11 gene. Family 21 whose autistic child displayed the transmitted mutation in the KTNAL2 gene. †de NOVO SNV, § transmitted SNV, * CNV We used data from He et al. 2017 , to create a layer expression profile for FEZF2 and nine other ASD associated genes. The expression of FEZF2 appears restricted to layer 5. Supplementary Figure 1 
Legends of Supplementary Figures
. Interactome network from products of genes found in de novo and transmitted CNVs for FEZF2 allele-unlinked (A) and linked (B) families.
Disease Association Protein-Protein Link Evaluator (DAPPLE) Network Derived from Genes hits found statistically significant networks linked to synapse for transmitted and de novo CNVs in FEZF2 allele-unlinked families (A). In contrast, a significant DAPPLE Network Derived from Genes hit is found only for repertoire involving both de novo and transmitted CNVs in FEZF2 allele-linked families (B).
Supplementary Figure 2. Spatiotemporal expression of ASD high-risk genes from 65 genes list of Sanders et al. 2015
We analysed spatiotemporal expression pattern trajectories of FEZF2 (A) and KATNAL2 (B) using the Brainscope resource (Huisman SMH et al., 2017 PMID: 28132031) . Their pattern is similar to that of 'red' (C) and 'black' (D) ensembles, respectively, as defined in Figure 7 .
Supplementary Figure 3. Multiple sequence alignment of DIP2A proteins from different species
We identified a mutation of the DIP2A protein (N553D) in Family n°2 linked to the FEZF2 allele.
This mutation occurs in a region fully conserved from Xenopus to primates, including humans.
Multiple sequence alignment of DIP2A protein sequences from human, mouse, chimpanzee, rat, Macaca mulatta, Xenopus, Bos Taurus, Sumatran Orangutan, and Macaca fascicularis, respectively.
Supplementary Figure 4. Multiple sequence alignment of NINL proteins from different species
We identified a mutation of the NINL protein (E673Q) in the Family n°6 linked to the FEZF2 allele.
This mutation occurs in a region conserved from rodents to primates, including humans.
Multiple sequence alignment of NINL protein sequences from human, mouse, chimpanzee, gorilla, Macaca nemestrina, Mandrillus leucophaeus, and Papio anubis, respectively.
Supplementary Figure 5. Multiple sequence alignment of AKAP9 proteins from different species
We identified a mutation of the AKAP9 protein (R1614Q) in the Family n°18 linked to the FEZF2 allele.
This mutation occurs in a region fully conserved from cat to primates, including humans. This mutation occurs in a region conserved from mouse to primates, including humans.
Multiple sequence alignment of ASH1L protein sequences from Human, mouse, rat, dog, Bos taurus, horse, cat, Macaca mulatta, pig, Cercopithecus sabaeus, Giant Panda, Macaca fascicularis, Bonobo, and White-tufted ear marmoset. Figure 10 . Multiple sequence alignment of SCN2A proteins from different species
Supplementary
We identified a mutation of the SCN2A protein (A34T) in Family n°23 linked to the FEZF2 allele.
This mutation occurs in a region conserved from chick to primates, including humans.
Multiple sequence alignment of SCN2A protein sequences from Human, mouse, rat, dog, cat, chimpanzee, chick, pig, Macaca mulatta, rabbit, Giant panda, gorilla, Bonobo, and Macaca fascicularis.
The D12N mutation in the same region (N-terminal cytoplasmic tail) identified by Ben-Shalom et al., 2017 is indicated.
Supplementary Figure 11. Multiple sequence alignment of ERN1 proteins from different species
We identified a mutation of the ERN1 protein (S536L) in Family n°2 linked to the FEZF2 allele.
This mutation occurs in a region conserved from zebrafish to primates, including humans.
Multiple sequence alignment of ERN1 protein sequences from Human, mouse, Macaca mulatta, cat, rat, horse, chimpanzee, dog, Bos taurus, gorilla, Papio anubis, Macaca fascicularis, Bonobo, Macaca nemestrina, sheep, Giant panda, and Sumatran orangutan.
Supplementary Figure 12. Multiple sequence alignment of STRIP2 proteins from different species
We identified a mutation of the STRIP2 protein (I308V) in Family n°6 linked to the FEZF2 allele.
Multiple sequence alignment of STRIP2 protein sequences from Human, mouse, dog, Macaca mulatta, cat, Bus Taurus, zebrafish, gorilla, chick, Giant panda, Sumatran orangutan, Papio anubis, horse, Macaca nemestrina, chimpanzee, and Bonobo.
Supplementary Figure 13. The position of the ZNF559 gene within the human genome and its primate-specific conservation
Site of the ZNF559 locus within the human genome (human HG38). Note that it is fully conserved in primates but not in other mammals, suggesting that ZNF559 is a primate-specific innovation.
